|
Sign In to gain access to subscriptions and/or personal tools.
|
Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?
J. E. Bailey
Psychopharmacology Unit, Medical School, University of Bristol, Bristol, UK
S. V. Argyropoulos
Psychopharmacology Unit, Medical School, University of Bristol, Bristol, UK
S. L. Lightman
University Research Centre for Neuroendocrinology, Medical School, University of Bristol, Bristol, UK
D. J. Nutt
Psychopharmacology Unit, Medical School, University of Bristol, Bristol, UK, david.j.nutt{at}bristol.ac.uk
The inhalation of carbon dioxide (CO2) is commonly used in patients and volunteers as a means of producing anxiety or panic. It is generally believed that patients with panic disorder are more vulnerable to the effects of CO2 than patients with other anxiety disorders or healthy volunteers and there is speculation and debate as to the mechanism for this apparent sensitivity. Recent work from our group has shown that a single inhalation of 35% CO2 activates the hypothalamic-pituitary-adrenocortical (HPA) axis, increases blood pressure (BP) and increases subjective fear responses in healthy volunteers. Correlation analyses reveal a relationship between the changes in BP and the cortisol increase. These findings led us to postulate that a common mechanism may mediate these and the subjective responses to inhalation of CO2. We propose that the noradrenergic system, particularly the locus coeruleus (LC), but including the A1 and A2 cell groups, may be a key mediator of these responses. This article examines the evidence and discusses the results of studies from our laboratory in relation to a neuroanatomical model centring on the LC.
Key Words: anxiety blood pressure carbon dioxide cortisol locus coeruleus noradrenaline (norepinephrine)
Journal of Psychopharmacology, Vol. 17, No. 3,
252-259 (2003)
DOI: 10.1177/02698811030173002

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Reed, J. Varon, B. T. Chait, and M. J. Kreek
Carbon Dioxide-Induced Anesthesia Results in a Rapid Increase in Plasma Levels of Vasopressin
Endocrinology,
June 1, 2009;
150(6):
2934 - 2939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Harvey, J. Hayashi, and D. R. Speigel
Chronic Obstructive Pulmonary Disease and Panic Disorder: Their Interrelationships and a Unique Utilization of Beta-Receptor Agonists
Psychosomatics,
November 1, 2008;
49(6):
546 - 546.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Nash, P. A. Sargent, E. A. Rabiner, S. D. Hood, S. V. Argyropoulos, J. P. Potokar, P. M. Grasby, and D. J. Nutt
Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study
The British Journal of Psychiatry,
September 1, 2008;
193(3):
229 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kasparov and A. G. Teschemacher
Altered central catecholaminergic transmission and cardiovascular disease
Exp Physiol,
June 1, 2008;
93(6):
725 - 740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Z. Poma, S. Milleri, L. Squassante, G. Nucci, M. Bani, G. I. Perini, and E. Merlo-Pich
Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects
J Psychopharmacol,
September 1, 2005;
19(5):
494 - 503.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fendt, S. Siegl, and B. Steiniger-Brach
Noradrenaline Transmission within the Ventral Bed Nucleus of the Stria Terminalis Is Critical for Fear Behavior Induced by Trimethylthiazoline, a Component of Fox Odor
J. Neurosci.,
June 22, 2005;
25(25):
5998 - 6004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Bailey
The Application of Good Clinical Practice to Challenge Tests
J Psychopharmacol,
March 1, 2004;
18(1):
16 - 16.
[PDF]
|
 |
|

|
 |

|
 |
 
E. Griez and K. Schruers
Mechanisms of CO2 Challenges
J Psychopharmacol,
September 1, 2003;
17(3):
260 - 262.
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bellodi, D. Caldirola, and A. Bertani
Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?
J Psychopharmacol,
September 1, 2003;
17(3):
263 - 264.
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Gorman
Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?
J Psychopharmacol,
September 1, 2003;
17(3):
265 - 266.
[PDF]
|
 |
|
|
|